We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

63 hedge funds and large institutions have $96.2M invested in Provention Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

33% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $1.38M

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

5% more funds holding

Funds holding: 60 → 63 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

27% less capital invested

Capital invested by funds: $131M → $96.2M (-$34.9M)

Holders
63
Holders Change
+3
Holders Change %
+5%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
20
Reduced
17
Closed
16
Calls
$1.83M
Puts
$1.38M
Net Calls
+$453K
Net Calls Change
-$1.5M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$6.99M
2
Invesco
Invesco
Georgia
+$4.57M
3
OM
Opaleye Management
Massachusetts
+$2.14M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.04M
5
EGI
EAM Global Investors
California
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.46M
2
ECM
ExodusPoint Capital Management
New York
-$1.33M
3
CS
Credit Suisse
Switzerland
-$1.31M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$1.05M
5
LCM
Laurion Capital Management
New York
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$406K +$479K +37,192 +536%
B
27
Bailard
California
$390K -$102K -7,900 -16%
SCM
28
Sio Capital Management
New York
$387K +$543K +42,100 New
RJFSA
29
Raymond James Financial Services Advisors
Florida
$379K -$23.2K -1,797 -4%
Wells Fargo
30
Wells Fargo
California
$366K -$170K -13,185 -25%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$331K -$1.46M -113,364 -76%
Verition Fund Management
32
Verition Fund Management
Connecticut
$314K -$1.05M -81,613 -71%
VEA
33
Virtus ETF Advisers
New York
$282K -$57.5K -4,461 -13%
Bank of America
34
Bank of America
North Carolina
$246K +$254K +19,702 +281%
TI
35
Trexquant Investment
Connecticut
$245K +$343K +26,610 New
CSS
36
Cubist Systematic Strategies
Connecticut
$241K +$337K +26,181 New
UBS Group
37
UBS Group
Switzerland
$238K +$64.4K +4,996 +24%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$207K -$322K -25,000 -53%
CS
39
Credit Suisse
Switzerland
$200K -$1.31M -101,948 -82%
IA
40
IndexIQ Advisors
New York
$199K +$279K +21,628 New
Lido Advisors
41
Lido Advisors
California
$197K -$226K -17,500 -45%
JGC
42
J. Goldman & Co
New York
$184K -$305K -23,661 -54%
Squarepoint
43
Squarepoint
New York
$177K +$53.1K +4,120 +27%
State Street
44
State Street
Massachusetts
$176K -$46.8K -3,630 -16%
SFG
45
SNS Financial Group
Minnesota
$171K +$239K +18,540 New
ECM
46
ExodusPoint Capital Management
New York
$160K -$1.33M -103,020 -86%
Morgan Stanley
47
Morgan Stanley
New York
$145K +$68.6K +5,320 +51%
CHAM
48
Clear Harbor Asset Management
Connecticut
$143K – – –
PMFA
49
Plante Moran Financial Advisors
Michigan
$138K +$193K +15,000 New
Charles Schwab
50
Charles Schwab
California
$134K – – –
1
2
3 4

PRVB Hedge Fund Activity: Q1 2020 in Review

63 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q1 2020, worth a combined $96.2M — down 27% from $131M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new PRVB positions and 16 closed out — a net gain of 6 holders — while 20 added to existing stakes and 17 trimmed.

The largest buyer was Millennium Management, adding an estimated $6.99M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $1.46M.

  • 63 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q1 2020, up from 60 in Q4 2019.
  • Funds reported $96.2M of Provention Bio, Inc. Common Stock stock for Q1 2020, down 27% quarter-over-quarter.
  • 22 funds opened new Provention Bio, Inc. Common Stock positions in Q1 2020 and 16 closed out, a net change of +6 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q1 2020 was Millennium Management, an estimated $6.99M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q1 2020 was Qube Research & Technologies (QRT), an estimated $1.46M sold.

Based on aggregated 13F filings for Q1 2020.